Scott Keating Email & Phone Number

Boston, Ma, Us

• Focus on non-opioid pain pharmacotherapy

Lawrence Township, Nj, Us

• Served as US indication lead for a CAR T-cell therapy in 3L+ large B-cell lymphoma (LBCL), 2L transplant eligible LBCL, 2L transplant-ineligible LBCL, and mantle cell lymphoma (MCL). • Independently led the launch of three indications: 3L+ LBCL, 2L transplant eligible LBCL, and 2L transplant ineligible LBCL. • Collaborate closely with key Medical, Commercial, Access, and customer-facing stakeholders to ensure a strategic initiative aligned, impactful evidence generation plan.• Led numerous health economic analyses using clinical trial data from single arm and controlled trials, collaborating with leading KOLs as needed.• Championed development of proactive communication tools including FDAMA 114 content, payer and institutional budget impact models, and burden of illness/unmet need decks. • Contribute health economic data to core resources such as AMCP dossier, rejection handlers, FAQ/Q&R documents, etc. • Support several cultural initiatives, serving as “Change Champion”, “Verified Inclusion Partner”, and "Onboarding Buddy"• Serve as a ‘Lead Reviewer’ on the Observational Protocol Review Committee.

Lawrence Township, Nj, Us

• Responsible for development of data generation strategy for launching brands, including economic models, budget impact models, cost-effectiveness model adaptations, and patient preference studies. • Led development of several proactive and reactive customer-facing resources, including training field teams on HEOR analyses. • Supported submission of New Technology Add-on Payment (NTAP) submission to Centers for Medicare & Medicaid Services. • Along with US HEOR leadership team, led development of 2021 Mission Statement and key performance indicators.

Lawrence Township, Nj, Us

• Developed and executed real-world data generation for in-line brands for multiple myeloma and chronic myeloid leukemia (Nov 2018 – Dec 2019), and launch activities for cell therapies (Jan 2020 onwards).• Independently designed, executed, and published real-world-data analyses capturing the clinical and economic value of established products. • Leveraged clinical trial, EMR, registry, and claims data for evidence generation. • Developed and presented scientific content to key opinion leaders at Medical and Access advisory boards. • Coordinated with Scientific Content teams on updates to reactive materials and AMCP dossiers; trained field personnel on HEOR analyses. • Co-lead planning and moderation of department-wide ‘Plan of Action’ meetings.

Leverkusen, North Rhine-Westphalia, De

• Updated and modified proactive budget impact models. • Developed and executed statistical analysis plans for claims-based retrospective observational studies.

New York, Ny, Us

• Designed and executed retrospective observational studies including a systematic literature review.• Analyzed EHR free text (natural language processing) and claims data using the R programming language. • Publish findings in peer-reviewed journals, and present scientific content at congresses.

Master'S Degree, Health Policy And Economics

Bachelor Of Science (Bs), Biochemistry And Molecular Biology Bachelor Of Science (Bs), Biology